Revance sees shares soar after acquisition barrier cleared

 Nashville-based Revance Therapeutics saw a nearly 26 percent jump in its stock value Monday morning following news that the biotech company has settled a distribution-related dispute with one of its customers. 

Swiss company Teoxane claimed that Revance, which focuses on neuromodulators related to aesthetics, breached a 2020 distribution agreement that made it the exclusive commercialization partner of Teoxane's line of dermal fillers.

https://www.nashvillepost.com/business/area_stocks/revance-clears-barrier-to-acquisition/article_313474b4-955e-11ef-9996-4fc077b45780.html